🔎 Trials Near Me

Beranda › Adenokarsinoma Esofagus › Arizona

Uji klinis Adenokarsinoma Esofagus di Arizona

10 studi untuk Adenokarsinoma Esofagus mencari peserta di lokasi di Arizona.

Kota di Arizona

Teks studi resmi (Bahasa Inggris)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • Kingman Regional Medical Center, Kingman
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05677490

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • City of Hope Cancer Center-Phoenix, Goodyear
  • Mayo Clinic Arizona, Phoenix
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

  • Mayo Clinic, Scottsdale
Menerima peserta
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05753748

A Study of KK2269 in Adult Participants With Solid Tumors

  • Mayo Clinic Arizona, Scottsdale
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06266299

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

  • Arizona Centers of Digestive Health, Gilbert
Menerima peserta
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT05530343

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

  • Research Site, Scottsdale
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT07284186

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

  • Mayo Clinic, Scottsdale
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT06071845

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

  • I-Mab Site 1016, Goodyear
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07432295

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.